 |
Prexton Therapeutics
Last updated: April 17, 2024
François Conquet, CEO and Founder
Country: Switzerland | Funding: $41.1M (+)
Website: http://www.prextontherapeutics.com/
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson's disease and other brain disorders. Prexton Therapeutics has the expertise to design novel mGluR4 compounds as new treatment for Parkinson's disease.
Website: http://www.prextontherapeutics.com/
Prexton Therapeutics has the mission to develop innovative drugs to improve the quality of life of people who suffer from Parkinson's disease and other brain disorders. Prexton Therapeutics has the expertise to design novel mGluR4 compounds as new treatment for Parkinson's disease.
